Correlation Between Aileron Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Aileron Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Aileron Therapeutics and Mineralys Therapeutics,
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Aileron and Mineralys is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.14 times less risky than Mineralys Therapeutics,. The stock trades about -0.37 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,350 in Mineralys Therapeutics, Common on September 4, 2024 and sell it today you would lose (63.00) from holding Mineralys Therapeutics, Common or give up 4.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Aileron Therapeutics |
| Mineralys Therapeutics, |
Aileron Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Aileron Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
| Mineralys Therapeutics, vs. Southwest Airlines | Mineralys Therapeutics, vs. SkyWest | Mineralys Therapeutics, vs. JetBlue Airways Corp | Mineralys Therapeutics, vs. Aegean Airlines SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |